RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,449,624 | +253.0% | 1,104,526 | +244.7% | 0.05% | +284.6% |
Q2 2023 | $2,393,485 | -20.3% | 320,413 | -28.8% | 0.01% | -35.0% |
Q1 2023 | $3,001,380 | -34.7% | 449,982 | -24.5% | 0.02% | -47.4% |
Q4 2022 | $4,595,677 | +150.3% | 596,067 | +245.5% | 0.04% | +90.0% |
Q3 2022 | $1,836,000 | +65.1% | 172,526 | +26.3% | 0.02% | +100.0% |
Q2 2022 | $1,112,000 | +49.9% | 136,626 | +31.8% | 0.01% | +150.0% |
Q1 2022 | $742,000 | -89.0% | 103,649 | -73.8% | 0.00% | -88.9% |
Q4 2021 | $6,769,000 | +332.5% | 395,134 | +480.9% | 0.04% | +227.3% |
Q3 2021 | $1,565,000 | – | 68,021 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |